GGrantIndex
← Leaderboards

Aaron Richard McCabe

Minnetronix, Inc.

$6,750,103
Attributed
$11,043,467
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY201421
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$11,043,467 · 8

By mechanism

R42$6,344,095 · 3
R44$4,024,509 · 2
R41$674,863 · 3

Top collaborators

Most similar at Minnetronix, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignDevicesCathetersSamplingCerebrospinal FluidDevice Or Instrument DevelopmentIn VivoCephalicHourMedical DeviceMorbidity - Disease RateIn VitroInnovationFiltrationNovel TherapeuticsSpinalExcisionClinical TrialsTranslatingMonitorAffectSafetyCollaborationsClinical Research

Grant awards (17)

Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter$395,323
R44 · FY2021 · NS · contact PI
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter$1,499,976
R44 · FY2020 · NS · contact PI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$939,151
R42 · FY2020 · AI · contact PI
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$637,111
R42 · FY2020 · CA · contact PI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$970,147
R42 · FY2019 · AI · contact PI
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$646,349
R42 · FY2019 · CA · contact PI
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter$561,439
R44 · FY2019 · NS · contact PI
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis$998,500
R42 · FY2018 · AI · contact PI
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases$665,919
R42 · FY2018 · CA · contact PI
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis$486,918
R42 · FY2018 · AI · contact PI
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis$1,000,000
R42 · FY2017 · AI · contact PI
Directed Chemotherapy Delivery for Leptomeningeal Metastases$224,970
R41 · FY2016 · CA · contact PI
Transcutaneous Energy Transmission System for Fully Implantable VADs$97,956
R44 · FY2016 · HL · contact PI
Transcutaneous Energy Transmission System for Fully Implantable VADs$721,018
R44 · FY2015 · HL · contact PI
Directed Antifungal Therapy for HIV-associated Cryptococcal Meningitis$224,976
R41 · FY2015 · AI · contact PI
Development of a Novel Therapeutic Approach for Cryptococcal Meningitis$224,917
R41 · FY2015 · AI · contact PI
Transcutaneous Energy Transmission System for Fully Implantable VADs$748,797
R44 · FY2014 · HL · contact PI